Effect of flunixin meglumine on selected physiologic and performance parameters of athletically conditioned thoroughbred horses subjected to an incremental exercise stress test.

This study investigates the impact of a dose of flunixin meglumine on exercise performance and physiological parameters in thoroughbred horses, finding that while the drug lowered certain inflammatory compounds, it did not enhance performance or significantly affect the animals’ drug elimination profiles.

Research Design and Participants

• The study involved twelve thoroughbred horses in good health and conditioned for athletic activity. These animals were exposed to an incremental exercise stress test, allowing researchers to assess their physiological responses and performance levels.

Methodology and Measurements

• The horses each received a single dose of flunixin meglumine—the dosage was consistent across all horses at 1.1 mg/kg, delivered via intravenous injection.
• The researchers utilised an enzyme-linked immunosorbent assay (ELISA) to detect the concentration of flunixin meglumine in the horses’ blood serum and urine.
• In addition to this drug concentration data, the research team also recorded performance metrics as well as hematology and clinical chemistry parameters in order to track the drug’s effects on the horses’ health and physical condition.

Study Design

• The study used a Latin-square design, which enables each participant—here, each horse—to operate as its own control. This minimises the effect of confounding variables and allows for more reliable comparison of pre- and post-dose data.

Key Findings

• It was discovered that flunixin meglumine lowered levels of prostaglandin F(1alpha) and thromboxane—compounds that typically rise during intense exercise, leading to inflammation.
• The research team noted, however, that the horses’ performance did not improve following administration of the drug, and there was no meaningful correlation between prostaglandin levels and the total running time during the exercise stress test.
• Additionally, the exercise regimen did not affect the rate at which the horses eliminated the drug—its concentrations fell below the detection limit of the ELISA test within 36 hours in serum and 120 hours in urine.